rs4141404
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005569.4(LIMK2):c.*758A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.792 in 152,248 control chromosomes in the GnomAD database, including 48,685 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.79 ( 48673 hom., cov: 33)
Exomes 𝑓: 0.75 ( 12 hom. )
Consequence
LIMK2
NM_005569.4 3_prime_UTR
NM_005569.4 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.774
Genes affected
LIMK2 (HGNC:6614): (LIM domain kinase 2) There are approximately 40 known eukaryotic LIM proteins, so named for the LIM domains they contain. LIM domains are highly conserved cysteine-rich structures containing 2 zinc fingers. Although zinc fingers usually function by binding to DNA or RNA, the LIM motif probably mediates protein-protein interactions. LIM kinase-1 and LIM kinase-2 belong to a small subfamily with a unique combination of 2 N-terminal LIM motifs and a C-terminal protein kinase domain. The protein encoded by this gene is phosphorylated and activated by ROCK, a downstream effector of Rho, and the encoded protein, in turn, phosphorylates cofilin, inhibiting its actin-depolymerizing activity. It is thought that this pathway contributes to Rho-induced reorganization of the actin cytoskeleton. At least three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.94 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LIMK2 | NM_005569.4 | c.*758A>C | 3_prime_UTR_variant | 16/16 | ENST00000331728.9 | NP_005560.1 | ||
LIMK2 | NM_016733.3 | c.*758A>C | 3_prime_UTR_variant | 15/15 | NP_057952.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LIMK2 | ENST00000331728.9 | c.*758A>C | 3_prime_UTR_variant | 16/16 | 1 | NM_005569.4 | ENSP00000332687 | A1 | ||
LIMK2 | ENST00000333611.8 | c.*758A>C | 3_prime_UTR_variant | 15/15 | 1 | ENSP00000330470 | P4 |
Frequencies
GnomAD3 genomes AF: 0.792 AC: 120424AN: 152090Hom.: 48620 Cov.: 33
GnomAD3 genomes
AF:
AC:
120424
AN:
152090
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.750 AC: 30AN: 40Hom.: 12 Cov.: 0 AF XY: 0.846 AC XY: 22AN XY: 26
GnomAD4 exome
AF:
AC:
30
AN:
40
Hom.:
Cov.:
0
AF XY:
AC XY:
22
AN XY:
26
Gnomad4 AFR exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.792 AC: 120532AN: 152208Hom.: 48673 Cov.: 33 AF XY: 0.790 AC XY: 58784AN XY: 74406
GnomAD4 genome
AF:
AC:
120532
AN:
152208
Hom.:
Cov.:
33
AF XY:
AC XY:
58784
AN XY:
74406
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2992
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at